Investigation of the regulation of Roundabout4 by hypoxia-inducible factor-1α in microvascular endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 4, 2015, Pages 2586-2594

  Tian, Rui ^a   Liu, Zaoxia ^a   Zhang, Hui ^a   Fang, Xuexun ^b   Wang, Chenguang ^a   Qi, Shounan ^a   Cheng, Yan ^a   Su, Guanfang ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Fibrovascular membranes; Hypoxia inducible factor 1 ; Microvascular endothelial cells; Proliferative diabetic retinopathy; Robo4

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; ROUNDABOUT RECEPTOR; ROUNDABOUT4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; MESSENGER RNA; PRIMER DNA; ROBO4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRDU ASSAY; CAPILLARY ENDOTHELIAL CELL; CELL CULTURE; CELL INVASION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; VITRECTOMY; WESTERN BLOTTING; CELL ADHESION; CELL HYPOXIA; CELL MOTION; CHEMISTRY; COMPLICATION; CONFOCAL MICROSCOPY; DERMIS; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; UPREGULATION; VASCULARIZATION; VITREOUS BODY;

AGED; CELL ADHESION; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DERMIS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA PRIMERS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROSCOPY, CONFOCAL; MICROVESSELS; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION; VITRECTOMY; VITREOUS BODY;

EID: 84939546371     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14409     Document Type: Article

References (32)

1. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res. 2006;83: 473-483.
2. Wang X, Wang G, Wang Y. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2009; 148:883-889.
3. Abu El-Asrar AM, Missotten L, Geboes K. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol. 2007;91:822-826.
4. Lim JI, Spee C, Hinton DR. A comparison of hypoxia-inducible factor-alpha in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients. Retina. 2010;30:1472-1478.
5. Jiang J, Xia XB, Xu HZ, et al. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. J Cell Physiol. 2009;218:66-74.
6. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE. 2005;2005:re12.
7. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15: 551-578.
8. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 1996;271:2746-2753.
9. Bunn HF, Gu J, Huang LE, Park JW, Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol. 1998;201:1197-1201.
10. Yamakawa M, Liu LX, Date T, et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003;93:664-673.
11. Huminiecki L, Gorn M, Suchting S, Poulsom R, Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics. 2002;79:547-552.
12. Grone J, Doebler O, Loddenkemper C, et al. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol Rep. 2006;15:1437-1443.
13. Huminiecki L, Bicknell R. In silico cloning of novel endothelial-specific genes. Genome Res. 2000;10:1796-1806.
14. Bedell VM, Yeo SY, Park KW, et al. roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A. 2005;102: 6373-6378.
15. Jones CA, London NR, Chen H, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med. 2008;14:448-453.
16. Huang L, Yu W, Li X, et al. Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. Mol Vis. 2009;15:1057-1069.
17. Ishikawa K, Yoshida S, Kadota K, et al. Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2010;51: 4307-4319.
18. Park KW, Morrison CM, Sorensen LK, et al. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol. 2003;261:251-267.
19. Xu K, Ding Q, Fang Z, et al. Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis. Cancer Gene Ther. 2010;17:212-222.
20. Mills CN, Joshi SS, Niles RM. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol Cancer. 2009;8:104.
21. Ozaki H, Yu AY, Della N, et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999; 40:182-189.
22. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-732.
23. Zhang X, Kon T, Wang H, et al. Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. Cancer Res. 2004;64:8139-8142.
24. Koshiji M, To KK, Hammer S, et al. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell. 2005;17:793-803.
25. Koch AW, Mathivet T, Larrive’ B, et al. Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Develop Cell. 2011;20:33-46.
26. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxiainducible factor 1. Circ Res. 2003;93:1074-1081.
27. Okada Y, Yano K, Jin E, et al. A three-kilobase fragment ofthe human Robo4 promoter directs cell type-specific expression in endothelium. Circ Res. 2007;100:1712-1722.
28. Okada Y. Transcriptional regulation of the endothelial cell-specific receptor, Robo4. Yakugaku Zasshi. 2012;132:1045-1049.
29. Okada Y. Regulation of endothelial cell-specific Robo4 gene expression by DNA methylation and non-lineage specific transcription factors. Yakugaku Zasshi. 2014;134:817-821.
30. Jin HO, An S, Lee HC, et al. Hypoxic condition-and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway. Cell Signal. 2007;19:1393-1403.
31. Tai TC, Wong-Faull DC, Claycomb R, et al. Hypoxic stress-induced changes in adrenergic function: role of HIF1 alpha. J Neurochem. 2009;109:513-524.
32. Wong DL, Tai TC, Wong-Faull DC, et al. Stress and adrenergic function: HIF1a, a potential regulatory switch. Cell Mol Neurobiol. 2010;30:1451-1457.